Centre Hospitalier Sainte-Anne Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00562289
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Centre hospitalier sainte Anne | CPN (INSERM U894) CH Sainte-Anne – Paris

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aneurysm (Phase 3)

Foramen Ovale, Patent (Phase 3)

Migraine Disorders (Phase 3)

Recurrence (Phase 3)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 5